WASHINGTON — The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them.

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. The drug Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was approved for marketing in 2012. The FDA said in a statement Monday that the digitally enhanced medication “works by sending a message from the pill’s sensor to a wearable patch.”

“Being able to track ingestion of medications prescribed for illness may be useful for some patients,” said Dr. Mitchell Mathis, director of the division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research. “The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how this technology might benefit patients and prescribers.”

Green-lighting the new medication, however, came with some caveats. Among them, the FDA said it was important to note that Abilify MyCite’s labeling asserts “the ability of the product to improve patient compliance with their treatment regimen has not been shown.”
Related ArticlesNovember 13, 2017

Jefferson County is locking up veterans in special jail unit to break the cycle of incarceration

November 11, 2017

Editorial: A smart shift on mental health for our veterans

November 10, 2017

The unforgettable moment a Minnesota widow touched the face that once belonged to her husband

November 7, 2017

Texas church gunman escaped from mental health facility in 2012 after threatening superiors

November 7, 2017

Texas church gunman once escaped from mental health center

“Abilify MyCite should not be used to track drug ingestion in ‘real-time’ or during an emergency,” the statement said, “because detection may be delayed or may not occur.”

In a portion of the statement that appeared to address privacy concerns, the FDA said the wearable patch that comes with the medication “transmits the information to a mobile application …read more

Source:: The Denver Post – News

(Visited 2 times, 1 visits today)
FDA approves first digital ingestion tracking system med

Leave a Reply

Your email address will not be published. Required fields are marked *